ArticleScientific reports2017

Pathway-based expression profiling of benign prostatic hyperplasia and prostate cancer delineates an immunophilin molecule associated with cancer progression.

Ankur Bhowal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.